Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Hypha Labs (FUNI) Notes Payables (2019 - 2025)

Hypha Labs filings provide 8 years of Notes Payables readings, the most recent being $354391.0 for Q3 2025.

  • On a quarterly basis, Notes Payables fell 67.13% to $354391.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $354391.0, a 67.13% decrease, with the full-year FY2025 number at $354391.0, down 67.13% from a year prior.
  • Notes Payables hit $354391.0 in Q3 2025 for Hypha Labs, down from $1.2 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $1.3 million in Q4 2021 to a low of $56705.0 in Q2 2021.
  • Median Notes Payables over the past 5 years was $665000.0 (2022), compared with a mean of $733162.6.
  • Biggest five-year swings in Notes Payables: soared 2212.2% in 2021 and later crashed 67.13% in 2025.
  • Hypha Labs' Notes Payables stood at $1.3 million in 2021, then plummeted by 37.88% to $791444.0 in 2022, then fell by 24.7% to $595965.0 in 2023, then soared by 80.92% to $1.1 million in 2024, then crashed by 67.13% to $354391.0 in 2025.
  • The last three reported values for Notes Payables were $354391.0 (Q3 2025), $1.2 million (Q2 2025), and $1.1 million (Q1 2025) per Business Quant data.